Bulletin
Investor Alert

Momenta Pharmaceuticals Inc.

NAS: MNTA

GO
/marketstate/country/us

After Hours

 --Quotes are delayed by 20 min

Aug 7, 2020, 4:58 p.m.

/zigman2/quotes/200094979/composite

$

32.99

Change

0.00 0.00%

Volume

Volume 20,497

Quotes are delayed by 20 min

/zigman2/quotes/200094979/composite

Previous close

$ 32.40

$ 32.99

Change

+0.59 +1.82%

Day low

Day high

$31.88

$33.29

Open

52 week low

52 week high

$11.29

$39.88

Open

Annual Financials for Momenta Pharmaceuticals Inc.

Fiscal year is January-December. All values USD millions. 20152016201720182019 5-year trend
Sales/Revenue 89.65M109.62M138.88M75.59M23.87M
Cost of Goods Sold (COGS) incl. D&A -----
COGS excluding D&A -----
Depreciation & Amortization Expense 8.66M9.12M9.18M11.07M12.76M
Depreciation 7.59M7.59M8.02M9.92M11.61M
Amortization of Intangibles 1.06M1.53M1.15M1.15M1.15M
Gross Income -----
20152016201720182019 5-year trend
SG&A Expense 165.43M175.22M206.76M198.04M281.6M
Research & Development 126.03M119.88M149.23M124M144.54M
Other SG&A 39.4M55.34M57.53M74.04M137.06M
Other Operating Expense ---30M-
Unusual Expense -(51.2M)15.5M17.81M27.6M
EBIT after Unusual Expense -(23.53M)(92.55M)(181.33M)(298.09M)
Non Operating Income/Expense 313,000298,00028,000(928,000)(1.17M)
Non-Operating Interest Income 808,0002.23M4.43M6.19M9.21M
Equity in Affiliates (Pretax) -----
Interest Expense -----
Gross Interest Expense -----
Interest Capitalized -----
Pretax Income (83.31M)(21M)(88.1M)(176.06M)(290.06M)
Income Tax -----
Income Tax - Current Domestic -----
Income Tax - Current Foreign -----
Income Tax - Deferred Domestic -----
Income Tax - Deferred Foreign -----
Income Tax Credits -----
Equity in Affiliates -----
Other After Tax Income (Expense) -----
Consolidated Net Income (83.31M)(21M)(88.1M)(176.06M)(290.06M)
Minority Interest Expense -----
Net Income (83.31M)(21M)(88.1M)(176.06M)(290.06M)
Extraordinaries & Discontinued Operations -----
Extra Items & Gain/Loss Sale Of Assets -----
Cumulative Effect - Accounting Chg -----
Discontinued Operations -----
Net Income After Extraordinaries (83.31M)(21M)(88.1M)(176.06M)(290.06M)
Preferred Dividends -----
Net Income Available to Common (83.31M)(21M)(88.1M)(176.06M)(290.06M)
EPS (Basic) (1.32)(0.31)(1.20)(2.26)(2.92)
Basic Shares Outstanding 63.13M68.66M73.14M77.85M99.34M
EPS (Diluted) (1.32)(0.31)(1.20)(2.26)(2.92)
Diluted Shares Outstanding 63.13M68.66M73.14M77.85M99.34M
EBITDA (75.78M)(65.61M)(67.88M)(152.45M)(257.73M)
Trending Tickers
  • /quotes/zigman/17636479/composite VUZI+15.60%
  • /quotes/zigman/237947/composite JCP-5.83%
  • /quotes/zigman/59392505/composite NUGT-2.93%
  • /quotes/zigman/59386294/composite JNUG-5.94%
  • /quotes/zigman/65801738/composite TLT+1.11%
X
Powered by StockTwits
Link to MarketWatch's Slice.